These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38700599)

  • 1. Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN).
    Galosi E; Costanzo R; Forcina F; Morino S; Antonini G; Salvetti M; Lauletta A; Luigetti M; Romano A; Primiano G; Guglielmino V; Fionda L; Garibaldi M; Esposito N; Falco P; di Pietro G; Truini A; Leonardi L
    Neurol Sci; 2024 Oct; 45(10):5023-5032. PubMed ID: 38700599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis.
    Berends M; Brunger AF; Bijzet J; Kroesen BJ; Drost G; Lange F; Teunissen CE; In 't Veld S; Vrancken AF; Gans ROB; Hazenberg BPC; van der Zwaag PA; Nienhuis HLA
    Amyloid; 2024 Jun; 31(2):132-141. PubMed ID: 38477065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative sensory testing and skin biopsy findings in late-onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO).
    Leonardi L; Costanzo R; Forcina F; Morino S; Antonini G; Salvetti M; Luigetti M; Romano A; Primiano G; Guglielmino V; Fionda L; Garibaldi M; Lauletta A; Rossini E; Tufano L; Ceccanti M; Esposito N; Falco P; di Pietro G; Truini A; Galosi E
    J Peripher Nerv Syst; 2023 Sep; 28(3):390-397. PubMed ID: 37535421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
    Louwsma J; Brunger AF; Bijzet J; Kroesen BJ; Roeloffzen WWH; Bischof A; Kuhle J; Drost G; Lange F; Kuks JBM; Gans ROB; Hazenberg BPC; Nienhuis HLA
    Amyloid; 2021 Mar; 28(1):50-55. PubMed ID: 32883119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis.
    Leonardi L; Adam C; Beaudonnet G; Beauvais D; Cauquil C; Not A; Morassi O; Benmalek A; Trassard O; Echaniz-Laguna A; Adams D; Labeyrie C
    Eur J Neurol; 2022 May; 29(5):1477-1487. PubMed ID: 35100482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation.
    Leonardi L; Galosi E; Vanoli F; Fasolino A; Di Pietro G; Luigetti M; Sabatelli M; Fionda L; Garibaldi M; Alfieri G; Lauletta A; Morino S; Salvetti M; Truini A; Antonini G
    Neurol Sci; 2022 Feb; 43(2):1359-1364. PubMed ID: 34189665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis.
    Cárdenas-Soto K; Dominguez XH; Cortes G; Tsai F; Saniger MDM; Guraieb-Chahin P; Torres-Ocatvo B; Gibbons C; Kelly JW; Freeman R; González-Duarte A
    J Peripher Nerv Syst; 2024 Jun; 29(2):221-231. PubMed ID: 38706223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between a commercial electrophysiological test of sudomotor function and intraepidermal nerve fiber density in hereditary transthyretin amyloidosis.
    Masuda T; Misumi Y; Nomura T; Yamakawa S; Tasaki M; Obayashi K; Ando Y; Ueda M
    Muscle Nerve; 2024 Jan; 69(1):99-102. PubMed ID: 37960924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?
    Romano A; Primiano G; Antonini G; Ceccanti M; Fenu S; Forcina F; Gentile L; Inghilleri M; Leonardi L; Manganelli F; Obici L; Sabino A; Sciarrone MA; Tozza S; Vitali F; Luigetti M
    Eur J Neurol; 2024 Jan; 31(1):e16070. PubMed ID: 37724995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis.
    Ticau S; Sridharan GV; Tsour S; Cantley WL; Chan A; Gilbert JA; Erbe D; Aldinc E; Reilly MM; Adams D; Polydefkis M; Fitzgerald K; Vaishnaw A; Nioi P
    Neurology; 2021 Jan; 96(3):e412-e422. PubMed ID: 33087494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice.
    Carroll AS; Razvi Y; O'Donnell L; Veleva E; Heslegrave A; Zetterberg H; Vucic S; Kiernan MC; Rossor AM; Gillmore JD; Reilly MM
    Amyloid; 2024 Jun; 31(2):95-104. PubMed ID: 38348665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy.
    Gasparotti R; Salvalaggio A; Corbo D; Agazzi G; Cacciavillani M; Lozza A; Fenu S; De Vigili G; Tagliapietra M; Fabrizi GM; Pareyson D; Obici L; Briani C
    J Neurol; 2023 Oct; 270(10):4827-4840. PubMed ID: 37329346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
    Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
    Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis-A Swiss reference center experience.
    Loser V; Benkert P; Vicino A; Lim Dubois Ferriere P; Kuntzer T; Pasquier J; Maceski A; Kuhle J; Theaudin M
    J Peripher Nerv Syst; 2023 Mar; 28(1):86-97. PubMed ID: 36471582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings.
    Galosi E; Leonardi L; Falco P; Di Pietro G; Fasolino A; Esposito N; Leone C; Di Stefano G; Inghilleri M; Luigetti M; Giovanni A; Truini A
    Amyloid; 2023 Mar; 30(1):59-66. PubMed ID: 36094793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional and structural evaluation of small fibers in asymptomatic carriers of TTR p.Val50Met (Val30Met) mutation.
    Bekircan-Kurt CE; Yilmaz E; Arslan D; Yildiz FG; Dikmetas Ö; Ergul-Ulger Z; Kocabeyoglu S; Irkec M; Hekimsoy V; Tokgozoglu L; Tan E; Erdem-Ozdamar S
    Neuromuscul Disord; 2022 Jan; 32(1):50-56. PubMed ID: 34980537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal excitability as an early biomarker of nerve involvement in hereditary transthyretin amyloidosis.
    Carroll AS; Park SB; Lin CSY; Taylor MS; Kwok F; Simon NG; Reilly MM; Kiernan MC; Vucic S
    Clin Neurophysiol; 2024 Mar; 159():81-95. PubMed ID: 38377648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative muscle ultrasound as a disease biomarker in hereditary transthyretin amyloidosis with polyneuropathy.
    Tan SY; Tan CY; Yahya MA; Low SC; Shahrizaila N; Goh KJ
    Neurol Sci; 2024 Jul; 45(7):3449-3459. PubMed ID: 38270729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic.
    Di Stefano V; Lupica A; Alonge P; Pignolo A; Augello SM; Gentile F; Gagliardo A; Giglia F; Brinch D; Cappello M; Di Lisi D; Novo G; Borgione E; Scuderi C; Brighina F
    Eur J Neurol; 2024 Jan; 31(1):e16065. PubMed ID: 37725003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
    Lin X; Yarlas A; Vera-Llonch M; Baranwal N; Biber J; Brown D; Vogt B; Karam C
    BMC Neurol; 2021 Feb; 21(1):70. PubMed ID: 33579211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.